Table 2:

Complications by aneurysm location and size subgroups

ComplicationsAnterior ICA ≥10 mm (n = 275)Anterior ICA <10 mm (n = 294)Posterior (n = 55)Other Anterior (n = 165)Total (n = 793)a95% CI; P Value
Mean aneurysm size (mm)16.8 ± 6.25.2 ± 2.214.5 ± 9.09.8 ± 7.910.7 ± 7.7(10.2–11.2); <.001
Spontaneous rupture4 (0.7%)0 (0.0%)0 (0.0%)1 (0.6%)5 (0.6%)(0.2%–1.5%); .17
Intraparenchymal hemorrhage6 (2.2%)6 (2.0%)1 (1.8%)6 (3.6%)19 (2.4%)(1.3%–3.4%); .73
Ischemic stroke15 (5.5%)8 (2.7%)4 (7.3%)10 (6.1%)37 (4.7%)(3.2%–6.2%); .16
Parent artery stenosis1 (0.4%)1 (0.4%)0 (0.0%)0 (0.0%)2 (0.3%)(0%–0.7%); 1.0
Cranial neuropathy2 (0.7%)0 (0.0%)0 (0.0%)0 (0.0%)2 (0.3%)(0%–0.7%); .30
Neurologic morbidity24 (8.7%)14 (4.5%)5 (9.1%)16 (9.7%)59 (7.4%)(5.6%–9.2%); .16
Neurologic mortality11 (4.0%)4 (1.4%)6 (10.9%)9 (5.5%)30 (3.8%)(2.5%–5.1%); <.01
Neurologic morbidity and mortality (all patients)26 (9.5%)14 (4.8%)9 (16.4%)18 (10.9%)67 (8.4%)(6.5%–10.3%); .01
Neurologic morbidity and mortality (patients with unruptured aneurysms)24/263 (9.2%)11/270 (4.1%)7/51 (13.7%)11/131 (8.4%)53/717 (7.4%)(5.5%–9.3%); .03
Neurologic morbidity and mortality (patients with ruptured aneurysms)2/12 (16.7%)3/24 (12.5%)2/4 (50.0%)7/34 (20.6%)14/76 (18.4%)(10.0%–27.1%); .35
Neurologic morbidity and mortality (excluding ruptured, dissecting, or fusiform aneurysms)15 (7.0%)9 (3.6%)3 (12.0%)6 (6.8%)33 (5.7%)(4.1%–7.3%); .19
  • Note:n indicates the number of patients.

  • a Numbers do not sum across categories and subcategories because some patients experienced >1 event.